GeneOne Life Science, Inc. (KRX:011000)

South Korea · Delayed Price · Currency is KRW

2,670.00

+2,136.00 (400.00%)

Jul 22, 2026, 7:45 AM KST

GeneOne Life Science Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	17,122	23,045	35,720	40,203	48,718	38,700
Revenue Growth	-53.96%	-35.48%	-11.15%	-17.48%	25.89%	-6.75%
Gross Profit	-13,415	-15,217	-10,967	-7,885	9,177	8,642
Operating Income	-37,314	-44,036	-43,039	-48,368	-40,199	-27,527
Net Income	-45,396	-51,851	-48,537	-77,768	-38,150	-15,888
Earnings Per Share	-2661.38	-3143.66	-3055.00	-5001.17	-2461.75	-1070.01
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	5,724	1,735	1,746	9,988	45,603	107,404
Total Debt	34,152	32,958	27,126	17,160	19,666	18,400
Net Cash (Debt)	-28,428	-31,223	-25,379	-7,171	25,937	89,004
Net Cash Growth	-	-	-	-	-70.86%	22.34%
Net Cash Per Share	-1666.62	-1893.01	-1597.43	-461.18	1673.65	5994.19

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-15,897	-16,541	-16,058	-21,744	-24,113	-4,849
Capital Expenditures	-23.82	-23.82	-3,298	-5,601	-45,306	-82,442
Free Cash Flow	-15,921	-16,565	-19,356	-27,345	-69,419	-87,291
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-78.35%	-66.03%	-30.70%	-19.61%	18.84%	22.33%
Operating Margin	-217.93%	-191.09%	-120.49%	-120.31%	-82.51%	-71.13%
Pretax Margin	-265.77%	-225.38%	-136.49%	-193.16%	-78.11%	-40.14%
Profit Margin	-265.13%	-225.00%	-135.88%	-193.44%	-78.31%	-41.05%
FCF Margin	-92.98%	-71.88%	-54.19%	-68.02%	-142.49%	-225.56%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	2.83	7.24	4.73	5.53	11.36	32.32